跳至主要内容
临床试验/NCT01225159
NCT01225159终止不适用

Safety and Efficacy of Tight Glycaemic Control During Cardiac Surgery

Prince of Songkla University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
200
试验地点
1
主要终点
Nosocomial Infection

研究概览

简要总结

To determine whether intraoperative tight glycaemic control can reduce postoperative infection, morbidity and mortality

详细描述

Hyperglycaemia develops frequently in patients undergoing cardiac surgery, especially following cardiopulmonary bypass (CPB). Recent evidence suggests that acute hyperglycaemia adversely affects immune function, wound healing and cardiovascular function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 15 years
  • cardiac surgery with cardiopulmonary bypass

排除标准

  • active infection
  • insulin allergy
  • off-pump cardiopulmonary bypass procedures

研究组 & 干预措施

Tight glycaemic control (TGC)

Experimental

TGC used hyperinsulinaemic normoglycaemic clamp with modified glucose-insulin-potassium to control blood sugar. The insulin (HumulinTM R, Lilly pharma, Germany) was diluted with normal saline to the concentration 1 IU. mL-1 and was infused continuously throughout the operations at a fixed rate of 0.3 IU. kg-1.h-1 but the maximal rate was 20 IU/ h. A separate mixture of glucose 25% (A.N.B Laboratories, Thailand) 50 mL, potassium chloride (Nida pharma, Thailand) 20 mEq and magnesium sulfate (Atlantic, Thailand) 2 gm was infused at 0.75 mL.kg-1.h-1 and was adjusted to maintain blood glucose levels 80-150 mg/dL.

干预措施: TGC (Drug)

Conventional glycaemic control (Control)

Placebo Comparator

Conventional glycaemic control aims to control blood sugar less than 250 mg%. Insulin was given bolusly if the blood sugar more than 250 mg%.

干预措施: Conventional glycaemic control (Drug)

结局指标

主要结局

Nosocomial Infection

时间窗: within the first 30 day after surgery

Infection rate referred to the rate of nosocomial infection, including pneumonia, central line infection, surgical wound infection, deep sternal wound infection, urinary tract infection, and sepsis. Infections were defined according to the Centers for Disease Control and Prevention (CDC) definitions, occurring within 30 days postoperative cardiac surgery.

次要结局

  • Morbidities and All Causes Mortality(within the first 30 days after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Panthila Rujirojindakul

Assistant Professor

Prince of Songkla University

研究点 (1)

Loading locations...

相似试验